Cargando…
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer
OBJECTIVES: Previous studies used enumerated circulating tumor cells (CTCs) to predict prognosis and therapeutic effect in several types of cancers. However, increasing evidence showed that only enumerated CTCs were not enough to reflect the heterogeneity of tumors. Therefore, we classified differen...
Autores principales: | Xu, Chang, Zhang, Chunhong, Wang, Haowen, Yang, Han, Li, Gang, Fei, Zhenghua, Li, Wenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384730/ https://www.ncbi.nlm.nih.gov/pubmed/28408845 http://dx.doi.org/10.2147/OTT.S118346 |
Ejemplares similares
-
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]
Publicado: (2017) -
FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC
por: Xu, Pei-Pei, et al.
Publicado: (2020) -
FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling
por: Chen, Ying, et al.
Publicado: (2020) -
The CHARGE syndrome-associated protein FAM172A controls AGO2 nuclear import
por: Sallis, Sephora, et al.
Publicado: (2023) -
[Retracted] FAM172A induces S phase arrest of HepG2 cells via Notch 3
por: Feng, Zhiqiang, et al.
Publicado: (2023)